These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6328146)

  • 1. Serotonergic stimulation of pituitary-adrenocortical activity in rats: evidence for multiple sites of action.
    Meyer JS; McElroy JF; Yehuda R; Miller J
    Life Sci; 1984 May; 34(20):1891-8. PubMed ID: 6328146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS; Buckholtz NS; Boggan WO
    Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin.
    Spinedi E; Gaillard RC
    J Endocrinol Invest; 1991; 14(7):551-7. PubMed ID: 1658112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and pituitary-adrenal function.
    Berger PA; Barchas JD; Vernikos-Danellis J
    Nature; 1974 Mar; 248(447):424-6. PubMed ID: 4363021
    [No Abstract]   [Full Text] [Related]  

  • 10. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the novel antidepressant tianeptine on L-5-hydroxytryptophan (5-HTP)-elicited corticosterone release and body weight loss.
    Broqua P; Baudrie V; Chaouloff F
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):115-20. PubMed ID: 1633432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of serotonin on the hypothalamic structures that participate in the regulation of the hypophyseal-adrenal cortex system].
    Maslova LN; Chernigovskaia EV; Belen'kiĭ MA; Danilova OA; Naumenko EV; Polenov AL
    Fiziol Zh SSSR Im I M Sechenova; 1990 Mar; 76(3):331-7. PubMed ID: 2164965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach study.
    Touret M; Sarda N; Gharib A; Geffard M; Jouvet M
    Exp Brain Res; 1991; 86(1):117-24. PubMed ID: 1836762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site of action of 5-hydroxytryptophan and 5-hydroxytryptamine on the hypothalamo-pituitary-adrenal system in vitro.
    Telegdy G; Kardos M
    Acta Physiol Acad Sci Hung; 1975; 46(3):253-6. PubMed ID: 198221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative feedback of corticosterone on the pituitary-adrenal axis is maintained after inhibition of serotonin synthesis with parachlorophenylalanine.
    Armario A; Martí O; Gavaldà A
    Brain Res Bull; 1992 Jun; 28(6):915-8. PubMed ID: 1322230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.
    Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB
    Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic stimulation of pituitary-adrenocortical function in rats.
    Fuller RW
    Neuroendocrinology; 1981 Feb; 32(2):118-27. PubMed ID: 7010191
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
    Van de Kar LD; Wilkinson CW; Ganong WF
    J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds.
    Le Feuvre RA; Aisenthal L; Rothwell NJ
    Brain Res; 1991 Aug; 555(2):245-50. PubMed ID: 1933336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.